MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Direct oral anticoagulants (DOAC s) have quickly become attractive alternatives to the long‐
standing standard of care in anticoagulation, vitamin K antagonist. DOAC s are indicated for …

Atrial fibrillation (AF) and chronic kidney disease (CKD) are closely related conditions with
shared risk factors. The growing prevalence of both AF and CKD indicates that more patients …

Atrial fibrillation (AF) and chronic kidney disease (CKD) often coexist as they share multiple
risk factors, including hypertension, diabetes mellitus, and coronary artery disease. Although …

The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …

Effective stroke prevention with oral anticoagulation (OAC) is the cornerstone of the
management of patients with atrial fibrillation. The use of OAC reduces the risk of stroke and …

Background Patients with chronic kidney disease (CKD) have an increased risk of venous
thromboembolism (VTE) and atrial fibrillation (AF). Anticoagulants have not been studied in …

Background Cognitive impairment is common in patients with chronic kidney disease (CKD),
and early intervention may prevent the progression of this condition. Methods Here, we …

Background Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in
clinical practice. The aim of this review was to evaluate the progress made in the …

Modern anticoagulation therapy has dramatically reduced the risk of stroke and systemic
thromboembolism in people with atrial fibrillation (AF). However, AF still impairs quality of …